COMMUNIQUÉS West-GlobeNewswire

Editas Medicine Presents Pre-Clinical Data for Treatment of Sickle Cell Disease and Beta-Thalassemia at the 24th Congress of the European Hematology Association
15/06/2019
IND-enabling activities initiated for EDIT-301, a potentially best-in-class experimental medicine for the treatment of sickle cell disease and beta-thalassemia CAMBRIDGE, Mass., June 15, 2019 (GLOBE NEWSWIRE) -- Editas [...]
Apellis Pharmaceuticals Presents Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at 24th European Hematology Association (EHA) Congress
15/06/2019
CRESTWOOD, Ky. and WALTHAM Mass., June 15, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Forty Seven, Inc. Announces Updated Data from Phase 1b/2 Clinical Trial of 5F9 in Combination with Rituximab in Patients with Relapsed/Refractory Non-Hodgkin’s Lymphoma
15/06/2019
-- 5F9 Well-Tolerated in Combination with Rituximab -- -- Durable Responses Observed in DLBCL and Indolent Lymphoma; Median Duration of Response Not Yet Reached -- -- Overall Response Rate (ORR) of 36% Observed in DLBCL [...]
Emerald Health Therapeutics applaudit le gouvernement du Canada pour la publication de la version définitive des réglementations encadrant les produits ingérables
15/06/2019
Le cadre de réglementation finale permet à Emerald de poursuivre sa croissance VANCOUVER, 15 juin 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (« Emerald ») (TSXV: EMH; OTCQX: EMHTF) est ravie que le [...]
Aclaris Therapeutics to Present at the 2019 JMP Securities Life Sciences Conference
14/06/2019
WAYNE, Pa., June 14, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced that [...]
UPDATE - OraSure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference
14/06/2019
[Updated Release to Correct Date of Presentation] BETHLEHEM, Pa., June 14, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, [...]
Emerald Health Therapeutics Applauds the Government of Canada for the Release of Final Ingestible Regulations
14/06/2019
Final regulatory framework positions Emerald for further growth VANCOUVER, British Columbia, June 14, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) is pleased that [...]
UPDATE - Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host Disease
14/06/2019
NEW YORK and MELBOURNE, Australia, June 14, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, today announced that it will host a virtual [...]
Canada House Wellness Group Inc. Update on Canada House Clinic Expansion
14/06/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“ Canada House ” or the “ Company ”), a fully [...]
Cytovance® Biologics Inc., Completes Its Second FDA Pre-Approval Inspection (PAI) of Oklahoma City, OK Facilities
14/06/2019
OKLAHOMA CITY, June 14, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics announced that it has received a notification letter and an Establishment Inspection Reports (EIRs) from the U.S. Food and Drug Administration (FDA) [...]
LifePod and iHome Announce Strategic Collaboration to Launch Groundbreaking Proactive-Voice Virtual Caregiver Service
14/06/2019
BOSTON, June 14, 2019 (GLOBE NEWSWIRE) -- During CE Week in New York, LifePod Solutions Inc. announced a strategic collaboration with SDI Technologies Inc., and their iHome division, to bring to market a first-of-its- [...]
Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host Disease
14/06/2019
NEW YORK and MELBOURNE, Australia, June 14, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, today announced that it will host a virtual [...]
Sienna Announces June Dividend
14/06/2019
MARKHAM, Ontario, June 14, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “ Common Share ”) [...]
Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report
14/06/2019
Loughborough, England, June 14, 2019 (GLOBE NEWSWIRE) -- – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible [...]
Avadim Health Announces the Launch of its Second Consumer Clinical Innovation, Theraworx® Relief for Arthritic Joint Discomfort and Inflammation
14/06/2019
Theraworx® Relief, for Arthritic Joint Discomfort and Inflammation, Launching in 22,000 Pharmacy Locations Nationwide ASHEVILLE, N.C., June 14, 2019 (GLOBE NEWSWIRE) -- Avadim Health, Inc. (“Avadim”), the Bionome [...]
SELLAS Life Sciences Announces Pricing of $15 Million Public Offering
14/06/2019
NEW YORK, June 14, 2019 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical stage biopharmaceutical company focused on the development of novel cancer [...]
Aura Signs Master Grower for Israel
14/06/2019
TORONTO, June 14, 2019 (GLOBE NEWSWIRE) -- Aura Health Inc. (the “ Company ” or “ Aura ”) ( CSE:BUZZ ) is pleased to announce the signing of master grower, Adrian Richelmi, to build and operate HolyCanna’s 60,000 square [...]
Krystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital Ichthyosis
14/06/2019
KB105 is a new gene therapy candidate engineered with a Transglutaminase-1 (TGM1) gene construct to treat TGM1 deficient autosomal recessive congenital ichthyosis KB105 is the second pipeline product based on the STAR-D [...]
ORYZON Presents Preliminary Dose Finding Results of Phase II Trial With Iadademstat in AML
14/06/2019
Results presented at 24 th Congress of EHA in Amsterdam Combination of iadademstat and azacitidine shows good safety profile in elderly AML patients Recommended dose for Phase II established with only six patients Quick [...]

Pages